Category: Cancer Research

Cancer Treatment Center of America (CTCA) Unveils a Leading-edge Clinical Pathways, a Customized Platform for Cancer Treatment


Cancer Treatment Centers of America has entered an innovative partnership with Allscripts and NantHealth, which will see the three partners execute a custom technical solution. This technical support solution allows eviti, a cutting-edge NantHealth clinical solution, to acquire information on clinical workflows on the electronic health record of Allscripts Sunrise. The Clinical Pathways program offers information about the cancer treatment procedure, without necessarily interfering with the doctor’s clinical workflow. Hundreds of oncologists based in the U.S. participated in the designing of the clinical operating system’s interface. The system harbors an all-inclusive collection of growing cancer care data.

As stated in the article, “Cancer Treatment Centers of America® Partners with Allscripts and NantHealth to Launch Clinical Pathways, a Comprehensive and Custom Oncology Treatment Platform,” Clinical Pathways avails all correct treatment alternatives. CMO of CTCA, George Daneker, said that the Clinical Pathways assists in the elimination of possible guesswork by physicians. The program incorporates new cancer research, treatment procedures, and alternative therapies into electronic health record (EHR) Allscripts Sunrise.

Benefits of the treatment platform

• Personalized treatment procedures that address the individual needs of patients, their health, as well as definite disease state

• Supported clinical data

Easy access to reliable information on adverse drug rates, response rates, and toxicity

• Instantaneous functionality

What is Cancer Treatment Centers of America?

The Florida-based Cancer Treatment Centers of America (CTCA) is a renowned national, for-profit partnership of five hospitals, which serve cancer patients across the U.S. CTCA approaches cancer treatment in an integrative manner that entails utilization of conventional techniques, such as chemotherapy, immunotherapy, radiation, and surgery, to manage cancer. Additionally, these hospitals provide integrative therapies to minimize side effects, including nausea, malnutrition, anxiety, lymphedema, fatigue, depression, and depression.

After cancer had claimed the life of his mother, Mr. Richard J Stephenson became more focused on finding an effective treatment for the life-threatening disease. He oversaw the launch of the first CTCA hospital back in 1988. Four other health care centers opened their doors from 2005 to 2012.

Supportive Therapies and Treatment Options Set The Cancer Treatment Centers of America Apart From Other Hospitals


Cancer Treatment Centers of America (CTCA) recently announced their adoption of the Clinical Pathways program, a NantHealth technology-based clinical decision support platform that will effectively organize all of the new cancer treatment information available to oncologists. Curated by oncologists, oncology associations, government agencies and more, the program offers information on more than 2,700 treatment options for all types of cancers.

According to Wikipedia, while the Clinical Pathways program makes it easy for oncologists to discuss options with their patients and to order a chemotherapy regimen, the program empowers patients as well. CTCA’s patients are able to view the same information as their oncologist about their available options, including response rates, clinical data, toxicity and more.

Based in Boca Raton, Florida, https://www.myctca.com/ operates five non-profit hospitals nationwide; in addition, they maintain a presence in the Caribbean, Latin America and the Middle East for individuals interested in visiting one of CTCA’s U.S. locations. CTCA is famous for their integrative approach to cancer treatments, which comprises of chemotherapy and radiation therapy, plus supportive therapies that combat stress, depression, pain and other effects of cancer treatments. Few cancer treatment centers offer the supportive therapies that the CTCA hospitals do, which include acupuncture, mind-body medicine, nutrition therapy and more.

At CTCA, all of the medical professionals specialize in patient-centered cancer care; patients select the latest technologies and therapies available to them after learning about all of their options from the Clinical Pathways program. Patients also enjoy coordinated care where all of their health care providers are located at one hospital.

For further information about CTCA follow them on Facebook.

Eric Lefkofsky : Using His Fortune to Fight Cancer


About Eric

Eric Lefkofsky is currently ranked at #1275 in the world’s billionaires’ list by Forbes with a net worth of $1.88 billion. He has amassed a significant percentage of his fortune from technology-based start-ups. He is the honcho at Groupon, 2010’s fastest growing entity, according to Forbes.

He has also worked in numerous prominent firms over his long career. Moreover, Lefkofsky is an active contributor to the fight against cancer as well as a passionate humanitarian.

Educational background

South Field Lathrup High was where Eric Lefkofsky received his secondary education. He attained his undergraduate BA degree from the University of Michigan. Eric later went to the Law school of the same university, where he was awarded Juris Doctor in 1993.

Accelerated Disruption

The book is an editorial masterpiece written by Eric. The primary subject matter covered is the bringing of entrepreneurial ideas into fruition. This piece is a step-by-step guide for successful businesses. Right from the first page, the book explains how to overcome obstacles as well as how you can transform your business into a client magnet. Additionally, it enlightens employers on how to treat their workers for best output.

Tempus Inc.

Over the years, Eric has displayed unrivaled commitment in the fight against cancer. Not only has he poured a significant amount of dollars towards the cause, but he also inaugurated Tempus Inc., an enterprise whose sole objective is to eradicate this menace.

Tempus is transforming the approach taken in diagnosing cancer. Rather than following conventional methods, the firm uses genetics to establish the extent of the disease. Genetic samples from patients are run through high-end laboratory infrastructure after which personalized medication is given to every client. The company uses modernized lab equipment to enhance the credibility of the test results.

Philanthropy

Eric has been involved in humanitarian causes since 2006 when he started his family foundation. The organization’s objective is to alleviate living standards of the impoverished. Over the years, the charity has supported numerous causes across the country, particularly the terminally ill, with a bias towards cancer patients.

Additionally, the group runs a mentorship program, named Moneythink. This incentive seeks to educate the youth on various financial issues.

Social Media: Facebook.com/eplefkofsky/

Just Who Is Clay Siegall & What Does He Do?


If you’re not too familiar with cancer research then you probably won’t recognize the name in this article, but this article is a great place to educate you on a very special individual. This individual has changed the game when it comes to the fight against cancer and his organization firmly sits at the top of the apex thanks to it’s great products and services. Clay Siegall is the name in question and Seattle Genetics is the organization he represents. Clay Siegall is by far one of the biggest names in cancer research and has been for some time now. He has led this valiant fight for many years while working with many high profile organizations such as Bristol Myers Squibb, The National Institute of Health, as well as The National Cancer Institute.

 

Clay Siegall has many titles thanks to his broad educational background. He’s known to be a scientist, philanthropist, guest speaker, fund raiser, and doctor. This brilliant minded individual attended the University of Maryland where obtained a (BS) in Zoology. The good doctor also earned a Ph.D in Genetics from the prestigious George Washington University. With all of these accomplishments you would think that he would be a household name, but unfortunately that isn’t the case. Dr. Siegall isn’t in it for fame, he’s in it to save lives and his company Seattle Genetics produces some of the best antibody based therapies in the business. These breakthrough therapies are known as (ADCs) aka Antibody Drug Conjugates. They specifically target cancerous cells within the body and attacks them with cell killing agents. This method is much more efficient as it spares all non-targeted cells within the body which cuts down on nasty side effects.

 

HeraldNet News reported that Seattle Genetics will be hiring at least 200 more employees in the near future in part by it’s huge growth. This will bring the company’s total up to around 1,100 in all. Dr. Siegall is the man in charge and will continue to see this progression through to the end.